KPRX | Kiora Pharmaceuticals, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	3.33 - 3.65
52 Week Range	3.00 - 8.98
Beta	N/A
Implied Volatility	N/A
IV Rank	N/A
Day's Volume	34,298
Average Volume	34,432
Shares Outstanding	2,970,540
Market Cap	10,129,541
Sector	Healthcare
Industry	Biotechnology
IPO Date	2015-02-13

Valuation
Profitability
Growth
Health
P/E Ratio	0.21
Forward P/E Ratio	N/A
EPS	16.53
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	12
Country	USA
Website	KPRX

Kiora Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, develops and commercializes therapies for the treatment of ophthalmic diseases in the United States. Its lead product is KIO-301, a potential vision-restoring small molecule, which is in Phase 1 clinical trial that acts as a photoswitch to restore vision in patients with inherited and age-related degenerative retinal diseases. The company is also developing KIO-101, an eye drop that is in Phase 2 clinical trial for the treatment of ocular presentation of rheumatoid arthritis, as well as for treating non-infectious posterior uveitis; and KIO-201, an eye drop, which is in Phase 3 clinical trial for treating patients undergoing PRK surgery for corneal wound repair after refractive surgery. The company was formerly known as Eyegate Pharmaceuticals, Inc. and changed its name to Kiora Pharmaceuticals, Inc. in November 2021. Kiora Pharmaceuticals, Inc. was incorporated in 1998 and is headquartered in Salt Lake City, Utah.

KPRX's peers: AIM, ENSC, HOTH, INDP, VRAX, BWV, REVB, HILS, QNRX, ALLR, KRBP, BDRX, UNCY, CDIO, PXMD, PBLA, PALI, KTTA, LGVN, NRBO, NRSN, PYPD, QLGN, SPRC, VRPX, VS, PEGY

*Chart delayed

Analyzing fundamentals for KPRX we got that it has weak fundamentals where Valuation is considered to be fairly valued, Profitability is poor, Growth is bad and Health is weak. For more detailed analysis please see KPRX Fundamentals page.

Watching at KPRX technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on KPRX Technicals page.